Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Personalized therapeutic delivery in the neurosurgical operating room.

Vogelbaum MA.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):8846-8848. doi: 10.1073/pnas.1812559115. Epub 2018 Aug 20. No abstract available.

PMID:
30127023
2.

Targeted Therapies for Brain Tumors: Will They Ever Deliver?

Vogelbaum MA.

Clin Cancer Res. 2018 Aug 15;24(16):3790-3791. doi: 10.1158/1078-0432.CCR-18-0855. Epub 2018 May 24.

PMID:
29798907
3.

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY.

Neuro Oncol. 2018 Jun 18;20(7):897-906. doi: 10.1093/neuonc/noy056.

PMID:
29788429
4.

Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC.

Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB, Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W, Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ, Gruber HE, Das A, Walbert T.

Neuro Oncol. 2018 Sep 3;20(10):1383-1392. doi: 10.1093/neuonc/noy075.

PMID:
29762717
5.

First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.

Vogelbaum MA, Brewer C, Barnett GH, Mohammadi AM, Peereboom DM, Ahluwalia MS, Gao S.

J Neurosurg. 2018 Apr 13:1-10. doi: 10.3171/2017.10.JNS171845. [Epub ahead of print]

PMID:
29652233
6.

Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report.

Laufer I, Lo SS, Chang EL, Sheehan J, Guckenberger M, Sohn MJ, Ryu S, Foote M, Muacevic A, Soltys SG, Chao S, Myrehaug S, Gerszten PC, Lis E, Maralani P, Bilsky M, Fisher C, Rhines L, Verlaan JJ, Schiff D, Fehlings MG, Ma L, Chang S, Parulekar WR, Vogelbaum MA, Sahgal A.

Neuro Oncol. 2018 Aug 2;20(9):1215-1224. doi: 10.1093/neuonc/noy047.

PMID:
29590465
7.

Risk Factors for Malignant Transformation of Low-Grade Glioma.

Murphy ES, Leyrer CM, Parsons M, Suh JH, Chao ST, Yu JS, Kotecha R, Jia X, Peereboom DM, Prayson RA, Stevens GHJ, Barnett GH, Vogelbaum MA, Ahluwalia MS.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):965-971. doi: 10.1016/j.ijrobp.2017.12.258. Epub 2017 Dec 21.

PMID:
29485076
8.

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2018 Jan;19(1):e33-e42. doi: 10.1016/S1470-2045(17)30692-7. Review.

PMID:
29304360
9.

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP.

J Neurosurg. 2018 Jul;129(1):35-47. doi: 10.3171/2016.11.JNS161170. Epub 2017 Oct 6.

10.

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Abbassy M, Missios S, Barnett GH, Brewer C, Peereboom DM, Ahluwalia M, Neyman G, Chao ST, Suh JH, Vogelbaum MA.

Neurosurgery. 2018 Sep 1;83(3):385-392. doi: 10.1093/neuros/nyx369.

PMID:
28973311
11.

Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.

Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, Montgomery JS, Habboub G, Vogelbaum MA, Suh JH, Murphy ES, Ahluwalia MS, Nagel SJ, Barnett GH.

J Neurosurg. 2018 Aug;129(2):366-382. doi: 10.3171/2017.3.JNS162532. Epub 2017 Sep 22.

PMID:
28937324
12.

Primary medical therapy for BRAFV600E-mutant melanoma brain metastases-is this good enough?

Kruser TJ, Vogelbaum MA.

Lancet Oncol. 2017 Sep;18(9):e508. doi: 10.1016/S1470-2045(17)30633-2. No abstract available.

PMID:
28884696
13.

Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria.

Sharma M, Juthani RG, Vogelbaum MA.

Chin Clin Oncol. 2017 Aug;6(4):37. doi: 10.21037/cco.2017.06.26. Review.

14.

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.

van den Bent MJ, Baumert B, Erridge SC, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, Clement PM, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Brachman DG, Taal W, Rudà R, Weller M, McBain C, Reijneveld J, Enting RH, Weber DC, Lesimple T, Clenton S, Gijtenbeek A, Pascoe S, Herrlinger U, Hau P, Dhermain F, van Heuvel I, Stupp R, Aldape K, Jenkins RB, Dubbink HJ, Dinjens WNM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, Wick W, Kros JM.

Lancet. 2017 Oct 7;390(10103):1645-1653. doi: 10.1016/S0140-6736(17)31442-3. Epub 2017 Aug 8. Erratum in: Lancet. 2017 Oct 7;390(10103):1644.

15.

Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.

Kotecha R, Miller JA, Venur VA, Mohammadi AM, Chao ST, Suh JH, Barnett GH, Murphy ES, Funchain P, Yu JS, Vogelbaum MA, Angelov L, Ahluwalia MS.

J Neurosurg. 2018 Jul;129(1):50-59. doi: 10.3171/2017.1.JNS162797. Epub 2017 Aug 11.

PMID:
28799876
16.

First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

Cancer Med. 2017 Sep;6(9):2076-2086. doi: 10.1002/cam4.1149. Epub 2017 Aug 4.

17.

Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.

Woody NM, Greer MD, Reddy CA, Videtic GMM, Chao ST, Murphy ES, Suh JH, Angelov L, Barnett GH, Vogelbaum MA, Stephans KL.

Clin Lung Cancer. 2018 Jan;19(1):e141-e147. doi: 10.1016/j.cllc.2017.06.011. Epub 2017 Jul 6.

PMID:
28739316
18.

Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain Metastasis.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

World Neurosurg. 2017 Oct;106:666-675. doi: 10.1016/j.wneu.2017.07.048. Epub 2017 Jul 19.

PMID:
28735139
19.

Evaluation of Prognostic Factors for Early Mortality After Stereotactic Radiosurgery for Brain Metastases: a Single Institutional Retrospective Review.

Bennett EE, Vogelbaum MA, Barnett GH, Angelov L, Chao S, Murphy E, Yu J, Suh JH, Elson P, Stevens GHJ, Mohammadi AM.

Neurosurgery. 2018 Jul 1;83(1):128-136. doi: 10.1093/neuros/nyx346.

PMID:
28673040
20.

Response Assessment in Neuro-Oncology Clinical Trials.

Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ.

J Clin Oncol. 2017 Jul 20;35(21):2439-2449. doi: 10.1200/JCO.2017.72.7511. Epub 2017 Jun 22. Review.

21.

PET imaging in patients with meningioma-report of the RANO/PET Group.

Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, Preusser M, Le Rhun E, Vogelbaum MA, Zadeh G, Dhermain F, Weller M, Langen KJ, Tonn JC.

Neuro Oncol. 2017 Nov 29;19(12):1576-1587. doi: 10.1093/neuonc/nox112. Review.

PMID:
28605532
22.

The Prognostic Role of Tumor Volume in the Outcome of Patients with Single Brain Metastasis After Stereotactic Radiosurgery.

Bennett EE, Angelov L, Vogelbaum MA, Barnett GH, Chao ST, Murphy ES, Yu JS, Suh JH, Jia X, Stevens GHJ, Ahluwalia MS, Mohammadi AM.

World Neurosurg. 2017 Aug;104:229-238. doi: 10.1016/j.wneu.2017.04.156. Epub 2017 May 3.

PMID:
28478250
23.

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J, Jaeckle K, Mehta M, Stupp R, Muzikansky A, Pentsova E, Cloughesy T, Iwamoto FM, Tonn JC, Vogelbaum MA, Wen PY, van den Bent MJ, Reardon DA.

Neuro Oncol. 2017 May 1;19(5):625-635. doi: 10.1093/neuonc/nox029. Review.

24.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):669-677. doi: 10.1093/neuonc/now208.

25.

The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.

Kim JM, Miller JA, Kotecha R, Xiao R, Juloori A, Ward MC, Ahluwalia MS, Mohammadi AM, Peereboom DM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Stevens GH, Chao ST.

J Neurooncol. 2017 Jun;133(2):357-368. doi: 10.1007/s11060-017-2442-8. Epub 2017 Apr 22.

PMID:
28434110
26.

Quality of Life following Stereotactic Radiosurgery for Single and Multiple Brain Metastases.

Miller JA, Kotecha R, Barnett GH, Suh JH, Angelov L, Murphy ES, Vogelbaum MA, Mohammadi A, Chao ST.

Neurosurgery. 2017 Jul 1;81(1):147-155. doi: 10.1093/neuros/nyw166.

PMID:
28327994
27.

Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases.

Kotecha R, Damico N, Miller JA, Suh JH, Murphy ES, Reddy CA, Barnett GH, Vogelbaum MA, Angelov L, Mohammadi AM, Chao ST.

Neurosurgery. 2017 Jun 1;80(6):871-879. doi: 10.1093/neuros/nyw147.

PMID:
28327948
28.

The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Suh JH, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Chao ST.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):e263-e273. doi: 10.1016/j.prro.2017.01.001. Epub 2017 Jan 5.

PMID:
28254368
29.

Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Chao ST, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Peereboom DM, Suh JH.

Cancer. 2017 Jun 15;123(12):2283-2293. doi: 10.1002/cncr.30616. Epub 2017 Feb 13.

30.

Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.

Alvarado AG, Thiagarajan PS, Mulkearns-Hubert EE, Silver DJ, Hale JS, Alban TJ, Turaga SM, Jarrar A, Reizes O, Longworth MS, Vogelbaum MA, Lathia JD.

Cell Stem Cell. 2017 Apr 6;20(4):450-461.e4. doi: 10.1016/j.stem.2016.12.001. Epub 2017 Jan 12.

31.

Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.

Miller JA, Bennett EE, Xiao R, Kotecha R, Chao ST, Vogelbaum MA, Barnett GH, Angelov L, Murphy ES, Yu JS, Ahluwalia MS, Suh JH, Mohammadi AM.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1060-1069. doi: 10.1016/j.ijrobp.2016.08.039. Epub 2016 Sep 1.

PMID:
27742540
32.

A cure is possible: a study of 10-year survivors of brain metastases.

Kotecha R, Vogel S, Suh JH, Barnett GH, Murphy ES, Reddy CA, Parsons M, Vogelbaum MA, Angelov L, Mohammadi AM, Stevens GHJ, Peereboom DM, Ahluwalia MS, Chao ST.

J Neurooncol. 2016 Sep;129(3):545-555. doi: 10.1007/s11060-016-2208-8. Epub 2016 Jul 25.

PMID:
27456950
33.

Gamma Knife radiosurgery for intracranial hemangioblastoma.

Silva D, Grabowski MM, Juthani R, Sharma M, Angelov L, Vogelbaum MA, Chao S, Suh J, Mohammadi A, Barnett GH.

J Clin Neurosci. 2016 Sep;31:147-51. doi: 10.1016/j.jocn.2016.03.008. Epub 2016 Jul 13.

PMID:
27422585
34.

Updates in the management of brain metastases.

Arvold ND, Lee EQ, Mehta MP, Margolin K, Alexander BM, Lin NU, Anders CK, Soffietti R, Camidge DR, Vogelbaum MA, Dunn IF, Wen PY.

Neuro Oncol. 2016 Aug;18(8):1043-65. doi: 10.1093/neuonc/now127. Review.

35.

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

Cloughesy TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu PL, Piccioni D, Walbert T, Chu A, Das A, Diago OR, Gammon D, Gruber HE, Hanna M, Jolly DJ, Kasahara N, McCarthy D, Mitchell L, Ostertag D, Robbins JM, Rodriguez-Aguirre M, Vogelbaum MA.

Sci Transl Med. 2016 Jun 1;8(341):341ra75. doi: 10.1126/scitranslmed.aad9784.

PMID:
27252174
36.

Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.

Mohammadi AM, Schroeder JL, Angelov L, Chao ST, Murphy ES, Yu JS, Neyman G, Jia X, Suh JH, Barnett GH, Vogelbaum MA.

J Neurosurg. 2017 Mar;126(3):735-743. doi: 10.3171/2016.3.JNS153014. Epub 2016 May 27.

PMID:
27231978
37.

The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.

Mansouri A, Mansouri S, Hachem LD, Klironomos G, Vogelbaum MA, Bernstein M, Zadeh G.

Cancer. 2016 Aug 15;122(16):2469-78. doi: 10.1002/cncr.30088. Epub 2016 May 16. Review.

38.

Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.

Otvos B, Silver DJ, Mulkearns-Hubert EE, Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale JS, Stoltz K, Sinyuk M, Wu Q, Jarrar A, Kim SH, Fox PL, Nakano I, Rich JN, Ransohoff RM, Finke J, Kristensen BW, Vogelbaum MA, Lathia JD.

Stem Cells. 2016 Aug;34(8):2026-39. doi: 10.1002/stem.2393. Epub 2016 May 27.

39.

The benefit of surgical resection in recurrent glioblastoma.

Vogelbaum MA.

Neuro Oncol. 2016 Apr;18(4):462-3. doi: 10.1093/neuonc/now004. Epub 2016 Feb 10. No abstract available.

40.

Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group.

Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn MJ, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten P, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlings MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A.

Lancet Oncol. 2015 Dec;16(16):e595-603. doi: 10.1016/S1470-2045(15)00166-7. Review.

PMID:
26678212
41.

Radiosurgery for Pediatric Brain Tumors.

Murphy ES, Chao ST, Angelov L, Vogelbaum MA, Barnett G, Jung E, Recinos VR, Mohammadi A, Suh JH.

Pediatr Blood Cancer. 2016 Mar;63(3):398-405. doi: 10.1002/pbc.25831. Epub 2015 Nov 4. Review.

PMID:
26536284
42.

Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.

Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M.

Neuro Oncol. 2016 Apr;18(4):565-74. doi: 10.1093/neuonc/nov247. Epub 2015 Oct 22.

43.

Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.

Alvarado AG, Turaga SM, Sathyan P, Mulkearns-Hubert EE, Otvos B, Silver DJ, Hale JS, Flavahan WA, Zinn PO, Sinyuk M, Li M, Guda MR, Velpula KK, Tsung AJ, Nakano I, Vogelbaum MA, Majumder S, Rich JN, Lathia JD.

Neuro Oncol. 2016 May;18(5):656-66. doi: 10.1093/neuonc/nov196. Epub 2015 Sep 15.

44.

The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.

Silver DJ, Sinyuk M, Vogelbaum MA, Ahluwalia MS, Lathia JD.

Neuro Oncol. 2016 Feb;18(2):153-9. doi: 10.1093/neuonc/nov157. Epub 2015 Aug 11. Review.

45.

Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases.

Ahluwalia MS, Chao ST, Parsons MW, Suh JH, Wang D, Mikkelsen T, Brewer CJ, Smolenski KN, Schilero C, Rump M, Elson P, Angelov L, Barnett GH, Vogelbaum MA, Weil RJ, Peereboom DM.

J Neurooncol. 2015 Sep;124(3):485-91. doi: 10.1007/s11060-015-1862-6. Epub 2015 Aug 6.

PMID:
26245136
46.

GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.

Mahata B, Biswas S, Rayman P, Chahlavi A, Ko J, Bhattacharjee A, Li YT, Li Y, Das T, Sa G, Raychaudhuri B, Vogelbaum MA, Tannenbaum C, Finke JH, Biswas K.

PLoS One. 2015 Jul 30;10(7):e0134425. doi: 10.1371/journal.pone.0134425. eCollection 2015.

47.

Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors.

Juthani RG, Bilsky MH, Vogelbaum MA.

Curr Treat Options Oncol. 2015 Aug;16(8):39. doi: 10.1007/s11864-015-0358-0. Review.

PMID:
26143269
48.

Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.

Vogelbaum MA, Hu C, Peereboom DM, Macdonald DR, Giannini C, Suh JH, Jenkins RB, Laack NN, Brachman DG, Shrieve DC, Souhami L, Mehta MP.

J Neurooncol. 2015 Sep;124(3):413-20. doi: 10.1007/s11060-015-1845-7. Epub 2015 Jun 19.

49.

Response assessment criteria for brain metastases: proposal from the RANO group.

Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2015 Jun;16(6):e270-8. doi: 10.1016/S1470-2045(15)70057-4. Epub 2015 May 27. Review.

PMID:
26065612
50.

Management of Brain Metastasis in Patients With Pulmonary Neuroendocrine Carcinomas.

Kotecha R, Zimmerman A, Murphy ES, Ahmed Z, Ahluwalia MS, Suh JH, Reddy CA, Angelov L, Vogelbaum MA, Barnett GH, Chao ST.

Technol Cancer Res Treat. 2016 Aug;15(4):566-72. doi: 10.1177/1533034615589033. Epub 2015 Jun 3.

PMID:
26041398

Supplemental Content

Loading ...
Support Center